论文部分内容阅读
α—糜蛋白酶过敏致死临床少见。现将遇见1例报告如下: 患者男,51岁,职工。因肺结核继发下胸椎结核,椎旁脓肿,并形成多处窦道已十余年。经抗痨治疗,切开引流,窦道刮除,久不愈,于1990年3月15日在全麻下行病灶清除术。术中顺利,术后良好。为促进创口愈合,肌注α—糜蛋白酶5mg。用后,出现头昏,气短,未处理,数分钟自行缓解。第二天又继用本品,当注入5mg后患者燥动不安,胸闷,气急,憋气,面色
α-chymotrypsin allergic to death clinically rare. Now meet one case reported as follows: Patient male, 51 years old, worker. Pulmonary tuberculosis secondary thoracic tuberculosis, paravertebral abscess, and the formation of multiple sinus has more than ten years. After anti-tuberculosis treatment, incision and drainage, curettage, long unhealed, in March 15, 1990 underwent focal debridement under general anesthesia. Intraoperative smooth, good after surgery. To promote wound healing, muscle injection of α-chymotrypsin 5mg. After use, dizziness, shortness of breath, untreated, a few minutes to ease themselves. The next day after the use of this product, when the injection of 5mg patients restlessness, chest tightness, shortness of breath, hold your breath, looking